Pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer and brain metastases (PERMEATE trial): overall survival results from a multicenter, single-arm, two-cohort, phase 2 trial

Authors

Institutions

Publication Details

Journal
EClinicalMedicine
Published
2024-09-20
DOI
https://doi.org/10.1016/j.eclinm.2024.102837
Citations
8
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
1.98
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer and brain metastases (PERMEATE trial): overall survival results from a multicenter, single-arm, two-cohort, phase 2 trial

Huawu Xiao, Xiuchun Chen, Huimin Lv, Fangzhou Xia et al.
8 citations
EClinicalMedicine
HER2/EGFR in Cancer Research
1.98
article

Pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer and brain metastases (PERMEATE trial): overall survival results from a multicenter, single-arm, two-cohort, phase 2 trial

Huawu Xiao, Xiuchun Chen, Huimin Lv, Fangzhou Xia, Huiai Zeng, Xiaorui Li, Fangyuan Dong, Limin Niu, Min Yan, Zhichao Gao, Lingxiao Zhang, Tao Sun, Huihui Sun, Yuhua Song, Zhenzhen Liu, Liping Liu, Li Li, Jing Wang, Yuting Chen, Jianghua Qiao, Guifang Zhang, Danfeng Dong, Chunfang Hao, Zhanhong Chen, Xiaohong Yang, Mengwei Zhang, Jin Yang, Yajing Feng, Quchang Ouyang
article en
8 citations

Abstract

No abstract available for this paper.
EClinicalMedicineVol. 76
Qingdao University (CN), Central South University (CN), Tianjin Medical University Cancer Institute and Hospital (CN), Zhengzhou University (CN), Hunan Cancer Hospital (CN), Affiliated Hospital of Qingdao University (CN), First Affiliated Hospital of Xi'an Jiaotong University (CN), Cancer Hospital of Chinese Academy of Medical Sciences (CN), Henan Cancer Hospital (CN), Jiangsu Hengrui Medicine (China) (CN), Xinxiang Central Hospital (CN), Liaoning Cancer Hospital & Institute (CN), Qilu Hospital of Shandong University (CN), University of Chinese Academy of Sciences (CN), China Medical University (CN)
Openalex Percentile: Top 11%
HER2/EGFR in Cancer Research
1.98
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.